Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways

Urological Research

Volumn 28, Issue 2, 2000, Pages 110-115

  Kühn, Rainer ^a   Ückert, Stefan ^a   Stief, Christian G ^a   Truss, Michael C ^a   Lietz, Burckhard ^b   Bischoff, Erwin ^c   Schramm, Matthias ^c   Jonas, Udo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b St Vincent Hospital   (Germany)

^c BAYER AG   (Germany)

Author keywords

Cyclic nucleotide monophosphates; Human ureter; Phosphodiesterase inhibitors; Phosphodiesterases

Indexed keywords

1 [6 CHLORO 4 (3,4 METHYLENEDIOXYBENZYLAMINO) 2 QUINAZOLINYL] 4 PIPERIDINECARBOXYLIC ACID; CYCLIC NUCLEOTIDE; DIHYDROPYRIDINE; FORSKOLIN; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; QUAZINONE; ROLIPRAM; ZAPRINAST;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; KIDNEY COLIC; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; URETER STONE;

EID: 0342657127     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050147     Document Type: Article

References (23)

1. Beavo J, Houslay MD (1990) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action. Wiley & Sons, Chichester
2. Boolell M, Allen M, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IA, Gingell C (1996) Sildenafil: an orally active type V cyclic GMP-specific phosphodiesterase-inhibitor for the treatment of erectile dysfunction. Int J Impot Res 8: 47-52
3. Braunwald E (1991) Intravenous milrinone: therapeutic responses in heart failure. Am Heart J 121: 1937
4. Bristol JA, Sircar L, Moos WH, Evans DB, Weishaar RE (1984) 4,5,-Dihydro-[4-(1H-imidazole-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure. J Med Chem 27: 1099-1101
5. Fisher AD, Smith JF, Pillar JS, St Denis S, Cheng JB (1998) Isolation and characterization of PDE9A, a novel cGMP-specific phosphodiesterase. J Biol Chem 273: 15559-15564
6. Fisher AD, Smith JF, Pillar JS, St Denis S, Cheng JB (1998) Isolation and characterization of PDE8A, a novel cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 246: 570-577
7. Gardner BP, Mandeville S, Glass C, Fraser M, Dinsmore WW, Muirhead G, Mayton MC, Orr M (1997) Sildenafil (Viagra): a double-blind, placebo-controlled, single-dose, two-way cross-over study in men with erectile dysfunction caused by traumatic spinal cord injury. J Urol 157(4): 181
8. Han P, Zhu X, Michaeli T (1997) Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272: 16152-16157
9. Hartmann M (1991) Urologische Notfallsituationen. In: Altwein JE, Rübben H (eds) Urologie. Enke, Stuttgart, pp 395-424
10. Komas N, Lugnier C, Stoclet JC (1991) Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104: 495-503
11. Lincoln TM (1989) Cyclic CMP and mechanisms of vasodilation. Pharmacol Ther 41: 479-484
12. Lowry OH, Rosebrough H, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 165-275
13. Lue TF (1997) A study of sildenafil (Viagra™), a new oral agent for the treatment of male erectile dysfunction. J Urol 157(4): 181
14. Michaeli T, Bloom TJ, Martins T, Loughney K, Ferguson K, Riggs M, Rodgers L, Beavo JA, Wigler M (1994) Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase deficient Saccharomyces cerevisiae. J Biol Chem 268(191): 12925-12932
15. Maurice DH, Haslam RJ (1990) Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. Eur J Pharmacol 191: 471-475
16. Nicholson CD, Chaliss RAJ, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12: 19-2
17. Opie LH (1982) Role of cyclic nucleotides in heart metabolism. Cardiovasc Res 16: 483-507
18. Stief CG, Ückert S, Truss MC, Becker AJ, Machtens S, Jonas U (1996) A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 24: 333-337
19. Taher A, Schulz-Knappe P, Meyer M, Truss MC, Forssmann WG, Stief CG, Jonas U (1994) Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol 12: 286-291
20. Thorphy TJ, Undem BJ (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46: 512-523
21. Thorphy TJ, Undem BJ, Cieslinski LB, Luttman MA, Reeves ML, Hay DWP (1993) Identification, characterization and functional role of phosphodiesterase isoenzymes in human airway smooth muscle. J Pharmacol Exp Ther 265: 1213-1222
22. Truss MC, Ückert S, Stief CG, Forssmann WG, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24: 129-134
23. Truss MC, Stief CG, Ückert S, Becker AJ, Forssmann WG, Jonas U (1997) Phosphodiesterase inhibition in lower urinary tract dysfunction: a possible new concept of treatment. Br J Urol [Suppl 2] 80: 6